Hereditary Angioedema Type III

Prevalence

5.0 / 100K

0 drugs in development·0 companies·2 clinical trials

Frequently asked questions

How many clinical trials target Hereditary Angioedema Type III?

There are 2 clinical trials targeting Hereditary Angioedema Type III tracked by BioSniper.

What is the prevalence of Hereditary Angioedema Type III?

The estimated prevalence of Hereditary Angioedema Type III is approximately 5.0 per 100,000 population.

Deep-dive into Hereditary Angioedema Type III

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Hereditary Angioedema Type III — Drugs in Development & Clinical Trials | BioSniper